Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 627 $32.13 $20,145.51
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 5

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,957

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 4

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 54 $32.13 $1,735.02
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,687

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
GrantCommon Stock 631 $27.32 $17,238.92
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,578

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 15, 2023 Filed May 17, 2023 22:13 UTC
Carpenter RickChief Technical Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,383 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · derivative · entry 4

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,765

Underlying: Common Stock · 2,383 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:13 UTC
Carpenter RickChief Technical Officer
Tax withholdingCommon Stock 825 $32.13 $26,507.25
Disclosure

SEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · nonDerivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,675

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:13 UTC
Carpenter RickChief Technical Officer
Exercise / conversionCommon Stock 2,383 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:13 UTC
Carpenter RickChief Technical Officer
GrantCommon Stock 454 $27.32 $12,403.28
Disclosure

SEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,117

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 12, 2023 Filed May 16, 2023 23:52 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
PurchaseCommon Stock 3,015 $32.77 $98,805.47
Disclosure

SEC source: 0001438133-23-000070 · wf-form4_168428115683623.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · Leigh A. Vosseller Trust

Disclosed balance after: 5,660

F1 · ownership.nature: The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:06 UTC
Carpenter RickChief Technical Officer
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000052 · wf-form4_167908716820308.xml · derivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,465

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 12/15/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 12/15/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:06 UTC
Carpenter RickChief Technical Officer
Tax withholdingCommon Stock 138 $42.14 $5,815.32
Disclosure

SEC source: 0001438133-23-000052 · wf-form4_167908716820308.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,663

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:06 UTC
Carpenter RickChief Technical Officer
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000052 · wf-form4_167908716820308.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 23:41 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionStock Option · Derivative 10,000 $18.86 Strike: $18.86 $188,600.00
Disclosure

SEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 23:41 UTC
BERGER DAVID BEVP & Chief Operating Officer
SaleCommon Stock 10,000 $41.19 $411,884.00
Disclosure

SEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.16 to $41.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 23:41 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionCommon Stock 10,000 $18.86 $188,600.00
Disclosure

SEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC
Leal JamesSVP, Operations
Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,548

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC
Leal JamesSVP, Operations
Tax withholdingCommon Stock 145 $35.87 $5,201.15
Disclosure

SEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,806

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC
Leal JamesSVP, Operations
Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:57 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,863

Underlying: Common Stock · 373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:57 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 153 $35.87 $5,488.11
Disclosure

SEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,332

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:57 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:41 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:41 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 166 $35.87 $5,954.42
Disclosure

SEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,692

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:41 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:36 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 819 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000046 · wf-form4_167771377846659.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,099

Underlying: Common Stock · 819 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:36 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 308 $35.87 $11,047.96
Disclosure

SEC source: 0001438133-23-000046 · wf-form4_167771377846659.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,979

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:36 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 819 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000046 · wf-form4_167771377846659.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,287

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:29 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000044 · wf-form4_167771336555785.xml · derivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:29 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 138 $35.87 $4,950.06
Disclosure

SEC source: 0001438133-23-000044 · wf-form4_167771336555785.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,851

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:29 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000044 · wf-form4_167771336555785.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000040 · wf-form4_167771216235917.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 154 $35.87 $5,523.98
Disclosure

SEC source: 0001438133-23-000040 · wf-form4_167771216235917.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,947

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000040 · wf-form4_167771216235917.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:35 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:35 UTC
BERGER DAVID BEVP & Chief Operating Officer
Tax withholdingCommon Stock 166 $35.87 $5,954.42
Disclosure

SEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:35 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:57 UTC
Hansen Shannon MarieSVP & General Counsel
Exercise / conversionRestricted Stock Unit · Derivative 2,123 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000016 · wf-form4_167667099763678.xml · derivative · entry 3

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,369

Underlying: Common Stock · 2,123 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 2/15/2022 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 2/15/2022 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:57 UTC
Hansen Shannon MarieSVP & General Counsel
Tax withholdingCommon Stock 866 $43.11 $37,333.26
Disclosure

SEC source: 0001438133-23-000016 · wf-form4_167667099763678.xml · nonDerivative · entry 2

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,591

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:57 UTC
Hansen Shannon MarieSVP & General Counsel
Exercise / conversionCommon Stock 2,123 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000016 · wf-form4_167667099763678.xml · nonDerivative · entry 1

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:04 UTC
Leal JamesSVP, Operations
Exercise / conversionRestricted Stock Unit · Derivative 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,508

Underlying: Common Stock · 168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:04 UTC
Leal JamesSVP, Operations
Tax withholdingCommon Stock 79 $43.11 $3,405.69
Disclosure

SEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,641

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:04 UTC
Leal JamesSVP, Operations
Exercise / conversionCommon Stock 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:38 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,462

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:38 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 67 $43.11 $2,888.37
Disclosure

SEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,112

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:38 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:18 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,462

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:18 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 67 $43.11 $2,888.37
Disclosure

SEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,451

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:18 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:15 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 792 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000022 · wf-form4_167667209130649.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,132

Underlying: Common Stock · 792 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.